Twist, Vivlion to generate gRNA libraries for CRISPR applications

By The Science Advisory Board staff writers

April 28, 2021 -- Twist Bioscience and Vivlion are collaborating to generate guide RNA (gRNA) libraries for CRISPR genome engineering applications and target discovery for drug development.

The collaboration will combine Twist's ability to generate uniform long oligos at scale with Vivlion's ability to translate the oligos into uniform CRISPR libraries for use in next-generation high-throughput CRISPR screenings.

Under the collaboration, Vivlion will purchase Twist oligo pools to generate and sell precision CRISPR libraries for functional genomics research. Vivlion's proprietary 3Cs technology will allow for direct conversion of oligo pools into gRNA libraries that maintain uniformity, including the generation of multiplexed and fixed-pair libraries.

Financial details of the collaboration were not disclosed.

Pure Biologics, Twist partner on immuno-oncology drugs
Pure Biologics and Twist Bioscience have partnered to accelerate the discovery of antibody-based immuno-oncology drugs.
Twist Bioscience purchases library designed with Distributed Bio
Twist Bioscience plans to exercise its option to purchase all rights to a G-coupled protein receptor library and its Twist antibody optimization software,...
Stanford gains access to Twist's 'library of libraries'
Twist Bioscience has granted Stanford University access to its antibody discovery and optimization services and its "library of libraries" for biologics...
Vivlion licenses CRISPR tech from ERS Genomics
Vivlion has signed a nonexclusive license agreement to access ERS Genomics' CRISPR/Cas9 patent portfolio to enhance Vivlion's gene editing reagents and...

Copyright © 2021 scienceboard.net


Conferences
Cell Bio 2021
December 11-15
San Diego, California United States
Antibody Engineering and Therapeutics
December 13-17
San Diego, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter